Page 5 - Biolase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biolase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biolase Today - Breaking & Trending Today

BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research report released on Wednesday morning. The brokerage issued a sell rating on the medical technology company’s stock. Several other equities analysts have also recently weighed in on BIOL. Lake Street Capital cut their target price on shares of BIOLASE to $1.50 […] ....

United States , Renaissance Technologies , Avantax Planning Partners Inc , Perkins Capital Management Inc , Biolase Inc , Citadel Advisors , Free Report , Street Capital , Get Free Report , Street Corp , Planning Partners , Perkins Capital Management , Capital Management , Nasdaq Biol , Initiated Coverage , Stocknews Com ,

BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the medical technology company’s stock. Other equities research analysts also recently issued research reports about the stock. Lake Street Capital reduced their target price on shares of BIOLASE […] ....

United States , Citadel Advisors , Perkins Capital Management Inc , Company Profile , Renaissance Technologies , Essex Investment Management Co , Biolase Inc , Get Rating , Street Capital , Street Corp , Investment Management , Perkins Capital Management , Capital Management , Nasdaq Biol , Initiated Coverage , Stocknews Com ,

BIOLASE, Inc. (NASDAQ:BIOL) Sees Significant Increase in Short Interest

BIOLASE, Inc. (NASDAQ:BIOL – Get Rating) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 2,090,000 shares, a growth of 145.4% from the May 15th total of 851,600 shares. Approximately 8.0% of the shares of the stock are sold short. […] ....

Armistice Capital , Citadel Advisors , Renaissance Technologies , Perkins Capital Management Inc , Biolase Inc , Essex Investment Management Co , Get Rating , Capital Management , Investment Management , Lake Street Capital , Nasdaq Biol ,

StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a report issued on Thursday morning. The brokerage issued a sell rating on the medical technology company’s stock. Several other research analysts have also commented on the company. Lake Street Capital cut their price objective on BIOLASE to $1.50 in a report on […] ....

Armistice Capital , Citadel Advisors , Essex Investment Management Co , Biolase Inc , Renaissance Technologies , Get Rating , Street Capital , Street Corp , Investment Management , Nasdaq Biol , Initiated Coverage , Stocknews Com ,